Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Saki Maeda‐Otsuka"'
Autor:
Kenichiro TANAKA, Ikko KAJIHARA, Kazuro SHIMOKAWA, Naotoshi NAKAMURA, Yudo KUSABA, Ryoko SAKAMOTO, Saki MAEDA-OTSUKA, Saori YAMADA-KANAZAWA, Soichiro SAWAMURA, Hisashi KANEMARU, Katsunari MAKINO, Jun AOI, Shinichi MASUGUCHI, Takashi SUZUKI, Satoshi FUKUSHIMA
Publikováno v:
European Journal of Dermatology; mar/apr2024, Vol. 34 Issue 2, p182-192, 93p
Autor:
Takehiro Ohnuma, Myangat Tselmeg Mijiddorj, Ikko Kajihara, Soichiro Sawamura, Ryoko Sakamoto, Saki Maeda‐Otsuka, Saori Yamada‐Kanazawa, Katsunari Makino, Jun Aoi, Shinichi Masuguchi, Satoshi Fukushima
Publikováno v:
The Journal of Dermatology.
Autor:
Yudo Kusaba, Ikko Kajihara, Tselmeg Mijiddorj Myangat, Kenichiro Tanaka, Ryoko Sakamoto, Saki Maeda‐Otsuka, Saori Yamada‐Kanazawa, Soichiro Sawamura, Hisashi Kanemaru, Yuki Nishimura, Kayo Nakamura‐Kashiwada, Katsunari Makino, Azusa Miyashita, Jun Aoi, Shinichi Masuguchi, Satoshi Fukushima
Publikováno v:
The Journal of Dermatology. 49:508-514
Although the prognosis of patients with extramammary Paget's disease (EMPD) treated with radical resection is good, the prognosis of EMPD with distant metastasis is very poor. PIK3CA mutations predict a good response to PIK3CA inhibitors. The aim of
Autor:
Saki Maeda-Otsuka, Myangat Tselmeg Mijiddorj, Ikko Kajihara, Yuki Nishimura, Hisashi Kanemaru, Soichiro Sawamura, Katsunari Makino, Jun Aoi, Shinichi Masuguchi, Satoshi Fukushima
Publikováno v:
BioScience Trends. 16:176-177
Dermatofibrosarcoma protuberans (DFSP) is a rare neoplasm derived from fibroblasts. Although the frequency of microsatellite instability (MSI) in skin cancer is reported to be less than 5%, there is only one report of the status of MMR in DFSP. The o
Autor:
Yudo Kusaba, Saori Yamada-Kanazawa, Jun Aoi, Katsunari Makino, Ikko Kajihara, Saki Maeda-Otsuka, Satoshi Fukushima, Shinichi Masuguchi, Soichiro Sawamura, Ryoko Sakamoto
Publikováno v:
The Journal of dermatologyREFERENCES. 48(10)
Autor:
Saki Maeda-Otsuka, Saori Yamada-Kanazawa, Katsunari Makino, Ikko Kajihara, Hironobu Ihn, Shinichi Masuguchi, Soichiro Sawamura, Ryoko Sakamoto, Tselmeg Mijiddorj Myangat, Satoshi Fukushima
Publikováno v:
The Journal of dermatologyReferences. 48(8)
Autor:
Satoshi Fukushima, Hironobu Ihn, Toshikatsu Igata, Saki Maeda-Otsuka, Saori Yamada-Kanazawa, Jun Aoi, Ikko Kajihara, Shinichi Masuguchi, Yuki Nakamura, Masatoshi Jinnin, Takamitsu Johno
Publikováno v:
Drug Discoveries & Therapeutics. 11:152-155
S-1, a 5-fluorouracil (5-FU)-based anti-cancer agent, is an important drug for treating metastatic extramammary Paget's disease (EMPD). Although intratumor expression levels of 5-FU metabolism enzymes have been studied widely in many solid tumors, no
Endoglin enhances the progression of angiosarcoma through the regulation of non-Smad TGF-β signaling
Autor:
Hironobu Ihn, Riichiro Abe, Daichi Hoshina, Yasuyuki Amoh, Mikio Masuzawa, Mamiko Masuzawa, Saori Yamada-Kanazawa, Saki Maeda-Otsuka, Ikko Kajihara, Ryoko Sakamoto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8feaa78bcc6874603d07af94d99fc9cf
https://doi.org/10.26226/morressier.5d4980d08fb7e44098e73069
https://doi.org/10.26226/morressier.5d4980d08fb7e44098e73069
Autor:
Soichiro Sawamura, Hironobu Ihn, Mamiko Masuzawa, Hisashi Kanemaru, Saori Yamada-Kanazawa, Jun Aoi, Ryoko Sakamoto, Saki Maeda-Otsuka, Riichiro Abe, Hitomi Miyauchi, Mikio Masuzawa, Ikko Kajihara, Yasuyuki Amoh, Takamitsu Makino, Satoshi Fukushima, Katsunari Makino, Daichi Hoshina
Publikováno v:
The Journal of investigative dermatology. 140(10)
Angiosarcoma is a rare malignant tumor derived from endothelial cells, and its prognosis is poor because advanced angiosarcoma is often resistant to taxane therapy. Endoglin (CD105) acts as a coreceptor for TGF-β signaling and is overexpressed in tu
Autor:
Yukino Tasaki, Saori Yamada-Kanazawa, Ryoko Sakamoto, Hironobu Ihn, Ikko Kajihara, Saki Maeda-Otsuka
Publikováno v:
Intractablerare diseases research. 8(1)
Extramammary Paget's disease (EMPD) is a rare skin malignant tumor. The prognosis of EMPD with distant metastasis is poor, however an effective therapy has not yet established. Recently, EpCAM (epithelial cell adhesion molecule, CD326) has attracted